You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
白雲山(00874.HK)旗下三間子公司等遭國家醫保局專項調查
國家醫保局發佈通報,對白雲山(00874.HK)(600332.SH)旗下天心製藥、白雲山製藥總廠及敬修堂藥業等三家企業藥品虛高定價、套取資金進行專項調查,責令三家企業及關聯企業全面整改營銷模式,對涉案人員,有關部門正在依紀依法查處。 通報並要求,三家企業對涉事藥物進行價格整改,剔除現行價格中用於賄賂等虛高部分,平均降幅50%以上,部分品規被停止採購。 經查,2017年至去年5月,天心製藥等三家藥品生產企業爲規避「兩票制」政策和監管,與下遊逾50家藥品代理商相互串通,對注射用頭孢硫(月米)等87種藥品,採取虛高價格採購原料藥的方式套現,並向下遊藥品代理商轉移資金,涉及金額巨大,其中部分資金用於行賄醫務人員或特定關係人,開展藥品違規促銷。(ta/w) ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account